Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alyssa L Siefert

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|February 3, 2017
Artificial Antigen-Presenting Cells for ImmunotherapiesAlyssa L Siefert, Tarek M Fahmy, Dongin Kim
Biomaterials|May 11, 2016
Artificial bacterial biomimetic nanoparticles synergize pathogen-associated molecular patterns for vaccine efficacyAlyssa L Siefert, Michael J Caplan, Tarek M Fahmy
Trends in Biotechnology|April 5, 2011
Pathogen-associated molecular patterns on biomaterials: a paradigm for engineering new vaccinesStacey L Demento, Alyssa L Siefert, Arunima Bandyopadhyay, et al.
Biomaterials|September 17, 2016
Immunomodulatory nanoparticles ameliorate disease in the Leishmania (Viannia) panamensis mouse modelAlyssa L Siefert, Allison Ehrlich, María Jesús Corral, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|December 7, 2018
The Yale Center for Biomedical Innovation and Technology (CBIT): One Model to Accelerate Impact From Academic Health Care InnovationAlyssa L Siefert, Malgorzata S Cartiera, Ayesha N Khalid, et al.
Nature Biomedical Engineering|October 7, 2021
Metabolic and immunomodulatory control of type 1 diabetes via orally delivered bile-acid-polymer nanocarriers of insulin or rapamycinJung Seok Lee, Patrick Han, Rabib Chaudhury, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|February 3, 2017
Artificial Antigen-Presenting Cells for ImmunotherapiesAlyssa L Siefert, Tarek M Fahmy, Dongin Kim
Biomaterials|May 11, 2016
Artificial bacterial biomimetic nanoparticles synergize pathogen-associated molecular patterns for vaccine efficacyAlyssa L Siefert, Michael J Caplan, Tarek M Fahmy
Trends in Biotechnology|April 5, 2011
Pathogen-associated molecular patterns on biomaterials: a paradigm for engineering new vaccinesStacey L Demento, Alyssa L Siefert, Arunima Bandyopadhyay, et al.
Biomaterials|September 17, 2016
Immunomodulatory nanoparticles ameliorate disease in the Leishmania (Viannia) panamensis mouse modelAlyssa L Siefert, Allison Ehrlich, María Jesús Corral, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|December 7, 2018
The Yale Center for Biomedical Innovation and Technology (CBIT): One Model to Accelerate Impact From Academic Health Care InnovationAlyssa L Siefert, Malgorzata S Cartiera, Ayesha N Khalid, et al.
Nature Biomedical Engineering|October 7, 2021
Metabolic and immunomodulatory control of type 1 diabetes via orally delivered bile-acid-polymer nanocarriers of insulin or rapamycinJung Seok Lee, Patrick Han, Rabib Chaudhury, et al.
Pageof 1